TMC PULSE

t m c » p u l s e | j u n e 2 0 1 4 34 ACCOLAdES dora e. angelaKi, M.d., professor and the Wilhelmina Robertson Chair in Neuroscience at Baylor College of Medicine, has been named to one of the nation's most prestigious honorary societies— the American Academy of Arts and Sciences. It brings together some of the world's most accom- plished leaders from academia, business, public affairs, the humanities and the arts. Angelaki's research focuses on multisensory integration that is needed for self-motion perception, spatial orienta- tion and the control of movement. She has also been elected to the National Academy of Sciences. hagoP KantarJian, M.d., professor and Department of Leukemia chair at The University of Texas MD Anderson Cancer Center, received a lifetime achievement award for his dedication to research and clinical practice from Castle & Connolly Medical Limited. Kantarjian leads the nation's largest leukemia practice, a department known for its extensive participation and leader- ship in the development of new treatments through research and clinical trials. He holds the Kelcie Margaret Kana Research Chair and serves as associate vice president of MD Anderson's Global Academic Programs. MarK w. Kline, M.d., physician-in-chief at Texas Children's Hospital and chair of pediatrics at Baylor College of Medicine, was presented with the Program for Global Pediatric Research (PGPR) Award for Outstanding Contributions to Global Child Health 2014. The ceremony took place during the 2014 PGPR symposium in conjunction with the 2014 Pediatric Academic Societies/Asian Society for Pediatric Research Joint Meeting. Kline was chosen as this year's recipient based on his significant contribution to changing the global child health landscape through capacity building, leadership training and program implementation focused on revolutionizing the care of children with HIV/AIDS in developing countries. thoMaS g. KSiazeK, Ph.d., professor of pathol- ogy at the University of Texas Medical Branch (UTMB) and director of high containment opera- tions for the Galveston National Laboratory, was recognized with a Lifetime Achievement Award at the 6th annual International Symposium on Filoviruses, which brings together experts from around the world to discuss advances in the diag- nosis, treatment and control of Ebola and Marburg viruses. Ksiazek also directs the National Biodefense Training Center, which provides researchers with the skills necessary to work safely with deadly pathogens in high-containment laboratories. walt lowe, M.d., chairman of the Department of Orthopaedic Surgery at The University of Texas Medical School at Houston and director of Memorial Hermann IRONMAN Sports Medicine Institute, has been recognized for his contributions to sports med- icine by the American Physical Therapy Association (APTA). Lowe received the Jack. C Hughston Sports Physician Award from the APTA's Sports Physical Therapy Section. Lowe has been treating Houston's top professional and college athletes for more than a decade and is a team physician for the Houston Texans and Houston Rockets, as well as the University of Houston. ceSar Maldonado, Ph.d., P.e., PMP, has been named chancellor of Houston Community College (HCC) by the HCC Board of Trustees. HCC conducted a nationwide search for the next leader of the institution by engaging a professional search firm and convening a diverse external group of 29 leaders, educators and students. Maldonado is an accomplished engineer, civic and business leader, and higher education administrator. Since 2008, he has served as president of Texas State Technical College (TSTC) in Harlingen. In 2011, he was also named vice chancellor for Institutional Effectiveness and Commercialization for the state- wide TSTC System. Martin M. MatzuK, M.d., Ph.d., director of the Center for Drug Discovery and vice chair of pathol- ogy and immunology at Baylor College of Medicine, has been elected to the National Academy of Sciences. Matzuk's research focuses on discovering the critical proteins and mechanisms involved in both normal and abnormal reproductive develop- ment. He is also a professor with the department of molecular and human genetics and co-director of the Medical Scientist Training Program (MSTP) at Baylor. fredericK a. MurPhy, Ph.d., professor of pathology at the University of Texas Medical Branch (UTMB), was recognized with a Lifetime Achievement Award at the 6th annual International Symposium on Filoviruses, which brings together experts from around the world to discuss advances in the diagnosis, treatment and control of Ebola and Marburg viruses. Murphy was the co-discoverer of this group of deadly viruses. Prior to his arrival at UTMB in 2005, he served in a number of prominent positions at the Centers for Disease Control and Prevention, concluding his career as director of the National Center for Infectious Diseases.

• Cover